Submitted:
11 May 2023
Posted:
18 May 2023
You are already at the latest version
Abstract
Keywords:
Introduction
Material and methods
Results
Risk factors
Exam results
Discussion
Conclusions
References
- John, WC. Large Artery Atherosclerotic Occlusive Disease. Continuum (Minneap Minn). 2017 Feb;23(1) (Cerebrovascular Disease):133-157. [CrossRef]
- Holman RL, McGill HC, Strong JP e Geer JC. The natural history of atherosclerosis: The early aortic lesions as seen in New Orleans in the middle of the 20th century. Am. J. Pathol. 1958 april;34(2) 209–235. PMCID: PMC1934740.
- Marques da Silva P, Lima MJ, Neves PM, Espiga de Macedo M. Prevalence of cardiovascular risk factors and other comorbidities in patients with hypertension in Portuguese primary health care populations: The PRECISE study. Rev Port Cardiol (Engl Ed)https://pubmed.ncbi.nlm.nih.gov/?term=%22Rev+Port+Cardiol+%28Engl+Ed%29%22%5Bjour%5Dhttps://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Rev+Port+Cardiol+%28Engl+Ed%29%22%5BTitle+Abbreviation%5Dhttps://pubmed.ncbi.nlm.nih.gov/31307727/. 2019 Jun;38(6):427-437. [CrossRef]
- Polonia J, Martins L, Pinto F, Nazare J. Prevalence, awareness, treatment and control of hypertension and salt intake in Portugal: Changes over a decade the PHYSA study. J Hypertens. 2014jun;32(6):1211–21. [CrossRef]
- Blaha, MJ. The future of CV risk prediction: Multisite imaging to predict multiple outcomes. JACC Cardiovasc Imaging. 2014;7(10):1054–6. ISSN 1936-878.
- Natural history of aortic and coronary atherosclerotic lesions in youth. Findings from the PDAY study. Pathobiological determinants of atherosclerosis in youth (PDAY) Research group Arterioscler. Thromb.1993 sep;13(9):1291–1298. [CrossRef]
- Santos MG, Pegoraro M, Sandrini F, Macuco EC. Risk Factors for the Development of Atherosclerosis in Childhood and Adolescence. Arq Bras Cardiol 2008; 90(4): 276-283. doi.org/10.1590/S0066-782X2008000400012.
- Kitamura A, Iso H, Imano H, Ohira T, Okada T, Sato S, et al. Carotid intima-media thickness and plaque characteristics as a risk factor for stroke in Japanese elderly men. Stroke. 2004 dec;35(12):2788–94. [CrossRef]
- Torres FS, Moreira CM, Vianna FF, Gus M. Medida da espessura das camadas íntima e média das artérias carótidas para avaliação do risco cardiovascular/ Intima-media thickness measurement for cardiovascular risk assessment. Rev. bras. Hipertens. 2007jul;14(3): 171-175.
- O'Leary DH, Bots ML. Imaging of atherosclerosis: carotid intima-media thickness. Eur. Heart J. 2010jul;31(14): 1682-9. [CrossRef]
- Sousa-Uva M, Dias CM. Prevalência de Acidente Vascular Cerebral na população portuguesa: dados da amostra ECOS 2013/2014.
- Perdigão C, Rocha E, Duarte JS, Santos A, Macedo A. Prevalência, caracterização e distribuição dos principais factores de risco cardiovascular em Portugal. Uma análise do Estudo AMÁLIA. Rev Port Cardiol. 2011;30(04):393-432.
- Casella IB, Presti C, Porta RMP, Sabbag CRD, Bosch MA, Yamazaki Y. A practical protocol to measure common carotid artery intima-media thickness. Clinics. 2008;63(4):515–20. [CrossRef]
- Pgnoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: A direct measurement with ultrasound imaging. Circulation. 1986;74(6):1399–406. [CrossRef]
- Ferguson GG, Eliasziw M, Barr HWK, Clagett GP, Barnes RW, Wallace MC, et al. The North American Symptomatic Carotid Endarterectomy Trial. Stroke. 1999sep;30(9):1751–8. [CrossRef]
- Ferguson GG, Eliasziw M, Barr HWK, Clagett GP, Barnes RW, Wallace MC, et al. The North American Symptomatic Carotid Endarterectomy Trial. Stroke. 1999sep;30(9):1751–8. [CrossRef]
- Diniz D, Correa M. The Helsinki Declaration: relativism and vulnerability. Cadernos de Saúde Pública/Ministério Da Saúde, Fundação Oswaldo Cruz, Escola Nacional de Saúde Publica. 2001jun; 17(3), 679-688. [CrossRef]
- Joakimsen O, Bønaa KH, Stensland-Bugge E, Jacobsen BK. Age and sex differences in the distribution and ultrasound morphology of carotid atherosclerosis: the Tromso Study. Arterioscler Thromb Vasc Biol. 1999dec;19(12):3007–13. [CrossRef]
- Rodrigues AP, Kislaya I, Graff-iversen S, Silva AC, Barreto M, Gil AP, et al. Prevalência de hipertensão arterial em Portugal: resultados do Primeiro Inquérito Nacional com Exame Físico (INSEF 2015)/Hypertension prevalence in Portugal: results from the first Portuguese Health Examination Survey 2015. Observações - Boletim Epidemiológico [Internet]. 2017;(2):11–4. ISSN: 0874-2928. Available from: www.insa.pt.
- Mariano C, Antunes M, Rato Q, Bourbon M. e_LIPID: caracterização do perfil lipídico da população portuguesa. Instituto Nacional de Saúde Doutor Ricardo Jorge, IP - Boletim Epidemiológico Observações. 2015out-dez;4(14):7–10. ISSN: 2182-88730874-2928.
- Correia LG, Boavida JM, Cardoso M, Duarte JS, Duarte R, Nunes JS, et al. Diabetes: Factos e Números 2016,2017 e 2018 - Relatório Anual do Observatório nacional da Diabetes. Portugal. Sociedade Portuguesa de Diabetologia. 2019.
- SNS. Consumo de tabaco em Portugal [Internet]. Serviço Nacional de Saúde. 2017. Available from: https://www.sns.gov. 2017.
- Bonhorst, D. Um novo olhar sobre a prevalência da fibrilhação auricular em Portugal. O Estudo Safira. Rev Port Cardiol. 2018;37(4):315–7. doi.org/10.1016/j.repc.2018.02.002.
- Naqvi TZ, Lee MS. Carotid intima-media thickness and plaque in cardiovascular risk assessment. JACC Cardiovasc Imaging. 2014;7(10):1025–38. [CrossRef]
- Freitas P, Piccinato CE, Martins WDP, Mauad Filho F. Carotid atherosclerosis evaluated by Doppler ultrasound: Association with risk factors and systemic arterial disease. J Vasc Bras. 2008;7(4):298–307. [CrossRef]
- Wang X, Li W, Song F, Wang L, Fu Q, Cao S, Yong G, Zhang W, Yue W, Yan F, Shi W, Wang X, Zhang H, Zhang H, Wang Z, Lu Z. Carotid atherosclerosis detected by ultrasonography: A national cross-sectional study. J Am Heart Assoc. 2018apr 5;7(8):1–14. [CrossRef]
- Huang LC, Lin RT, Chen CF, Chen CH, Hank Juo SH, Lin HF. Predictors of carotid intima-media thickness and plaque progression in a chinese population. J Atheroscler Thromb. 2016;23(8):940–9. [CrossRef]
- Zhang L, Fan F, Qi L, Jia J, Yang Y, Li J, et al. The association between carotid intima-media thickness and new-onset hypertension in a Chinese community-based population. BMC Cardiovasc Disord. 2019;19(269):1–6. [CrossRef]
- Carvalho ACA de, Oliveira LS de AF, Melo DP de, Crusoé- Rebello I, Campos PSF. Desenvolvimento de placas de ateroma em pacientes diabéticos e hipertensos. Rev Ciências Médicas e Biológicas. 2010;9(1):73. [CrossRef]
- Ji X, Leng X-Y, Dong Y, Ma Y-H, Xu W, Cao X-P, Hou X-H, Dong Q, Tan L. Yu J. Modifiable risk factors for carotid atherosclerosis: a meta-analysis and systematic review. Ann Transl Med. 2019nov;7(22):632–632. [CrossRef]
- Triches C, Schaan BDA, Gross JL, Azevedo MJ. Complicações macrovasculares do diabetes melito: Peculiaridades clínicas, de diagnóstico e manejo. Arq Bras Endocrinol Metabol. 2009;53(6):698–708. [CrossRef]
- Amarante RDM, Castro R, Lage AV, Cisternas JR. Diabetes Mellitus como fator de risco na aterogênese. Arquivos Médicos dos Hospitais e da Faculdade de Ciências Médicas da Santa Casa de São Paulo. 2007;52(3):87–93.
- Kamel H, Healey JS. Cardioembolic Stroke. Circ Res. 2017;120(3):514–26. [CrossRef]
| Variable | Absolut frequencies | Percentage (%) | |
|---|---|---|---|
| Personal history of stroke | No | 4073 | 69,2% |
| Yes | 1812 | 30,8% | |
| Personal history of AMI | No | 5464 | 92,8% |
| Yes | 421 | 7,2% | |
| Family history of stroke | No | 5816 | 98,8% |
| Yes | 69 | 1,2% | |
| Family history of AMI | No | 5844 | 99,3% |
| Yes | 41 | 0,7% | |
| Hypertension | No | 1098 | 18,7% |
| Yes | 4787 | 81,3% | |
| Dyslipidemia | No | 2867 | 48,7% |
| Yes | 3018 | 51,3% | |
| Diabetes mellitus | No | 4036 | 68,6% |
| Yes | 1849 | 31,4% | |
| Smoke habits | No | 4864 | 82,7% |
| Yes/ex-smoker | 1021 | 17,3% | |
| AF | No | 5025 | 85,4% |
| Yes | 860 | 14,6% | |
| Other cardioembolic heart disease | No | 5675 | 96,4% |
| Yes | 210 | 3,6% | |
| Variables | Absolut frequencies | Percentage (%) | |
|---|---|---|---|
| Carotid axes | Normal | 803 | 13,6% |
| Atheromatous plaques, without hemodynamic repercussions | 3776 | 64,2% | |
| Moderate stenosis | 359 | 6,1% | |
| Pre-occlusive stenosis | 315 | 5,4% | |
| Occlusion | 197 | 3,3% | |
| Other | 435 | 7,4% | |
| Vertebral axes | Normal | 5507 | 93,6% |
| Atheromatous plaques, without hemodynamic repercussions | 36 | 1,2% | |
| Moderate stenosis | 15 | 0,3% | |
| Pre-occlusive stenosis | 14 | 0,3% | |
| Occlusion | 139 | 2,4% | |
| Other | 174 | 2,2% | |
| Variables | Cervical Doppler results | ||||
|---|---|---|---|---|---|
| Normal (%) |
Pathologic with hemodinamic repercurssion <70% | Pathologic with hemodinamic repercurssion >70% | |||
| Non-modifiable risk factors | Sex | female | 6,9% | 32,6% | 2,3% |
| male | 5,8% | 46,7% | 5,7% | ||
| Personal history of stroke | No | 10,6% | 54,2% | 4,4% | |
| Yes | 2,1% | 25,1% | 3,6% | ||
| Personal history of AMI | No | 12,1% | 83,4% | 7,3% | |
| Yes | 0,5% | 5,8% | 0,9% | ||
| Family history of stroke | No | 12,6% | 78,2% | 8% | |
| Yes | 0,2% | 0,9% | 0% | ||
| Family history of AMI | No | 12,6% | 78,8% | 7,9% | |
| Yes | 0,1% | 0,6% | 0% | ||
| Modifiable risk factors | Hypertension | No | 3,4% | 13,9% | 1,4% |
| Yes | 9,3% | 65,3% | 6,7% | ||
| Dyslipidemia | No | 6,9% | 37,9% | 3,9% | |
| Yes | 5,7% | 41,5% | 4,1% | ||
| Diabetes mellitus | No | 9,5% | 53,5% | 5,6% | |
| Yes | 3,2% | 25,8% | 2,4% | ||
| Smoke habits | No | 11,3% | 65,1% | 6,3% | |
| Yes/ex-smoker | 1,3% | 14,2% | 1,8% | ||
| AF | No | 11,1% | 67,3% | 7% | |
| Yes | 1,6% | 12% | 1% | ||
| Other cardioembolic heart disease | No | 12,4% | 76,3% | 7,7% | |
| Yes | 0,3% | 3% | 0,3% | ||
| Variable pairs | p-value | |
|---|---|---|
| Non-modifiable risk factos | sex vs IMI | 0,000 |
| sex vs carotid axes/vertebral axes | 0,000/0,000 | |
| age vs IMI* | 0.002 | |
| age vs carotid axes/vertebral axes** | 0.118/0.063 | |
| personal history of stroke vs IMI | 0,000 | |
| personal history of stroke vs carotid axes/vertebral axes | 0,000/0,000 | |
| personal history of AMI vs IMI | 0,327 | |
| personal history of AMI vs carotid axes/vertebral axes | 0,000/0,000 | |
| family history of stroke vs IMI | 0,895 | |
| family history of stroke vs carotid axes/vertebral axes | 0,083/1 | |
| family history of AMI vs IMI | 0,928 | |
| family history of AMI vs carotid axes/vertebral axes | 0,343/0,021 | |
| Variable pairs | p-value | |
|---|---|---|
| Modifiable risk factors | arterial hypertension vs IMI | 0,183 |
| arterial hypertension vs carotid axes/vertebral axes | 0,000/0,016 | |
| DM vs IMI | 0,316 | |
| DM vs carotid axes/vertebral axes | 0,000/0,039 | |
| dyslipidemia vs IMI | 0,418 | |
| dyslipidemia vs carotid axes/vertebral axes | 0,000/0,131 | |
| smoke habits vs IMI | 0,000 | |
| smoke habits vs carotid axes/vertebral axes | 0,000/0,000 | |
| AF vs IMI | 0,103 | |
| AF vs carotid axes/vertebral axes | 0,000/0,743 | |
| other cardioembolic heart disease vs IMI | 0,412 | |
| other cardioembolic heart disease vs carotid axes/vertebral axes | 0,745/0,270 | |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
